Eureka Genomics next-gen genotyping (NGG) offer an improved and economical alternative to traditional technologies for genotyping hundreds to thousands of samples using Next Generation Sequencing (NGS). The assay can be broadly applied to the detection of single nucleotide polymorphisms (SNPs), copy number variation (CNV), gene expression and methylation and is compatible with DNA or RNA from virtually any organism, even when genome information may be incomplete.
Eureka Genomics Next Generation Sequencing (NGS) services provide comprehensive solutions for challenging research questions. Whether sequencing for rare variant detection, 16S metagenomic analysis, detection of foreign nucleic acids or characterization of microbial evolution, Eureka Genomics provides core expertise in sample preparation and sequencing. Backed by proprietary analytical software, Eureka Genomics provides synthesis of sequencing results, capturing the significance of every project and reporting results in a meaningful way.
Eureka Genomics' core bioinformatics technology was originally developed at the University of Houston Bioinformatics Lab. The exceptional efficiency of the Eureka Genomics algorithms, databases and software coupled with the ability to manipulate huge amounts of genomic data, creates a unique opportunity to perform sophisticated analysis on a large number of genomic sequences (from animals, plants, insects and/or microbes) in conjunction with the data produced by NGS technology.